These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9775281)

  • 41. [Interpretation of efficacy measures derived from 2 X 2 tables for the evaluation of diagnostic tests and treatment].
    Bender R
    Med Klin (Munich); 2001 Feb; 96(2):116-21. PubMed ID: 11253283
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The trap of percentages].
    Bobbio M
    Riv Inferm; 1993; 12(4):231-4. PubMed ID: 8171244
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Measures of effect: relative risks, odds ratios, risk difference, and 'number needed to treat'.
    Tripepi G; Jager KJ; Dekker FW; Wanner C; Zoccali C
    Kidney Int; 2007 Oct; 72(7):789-91. PubMed ID: 17653136
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Four numbers and basic knowledge of mathematics].
    Suter K; Briel M; Günther J
    Med Monatsschr Pharm; 2015 Jan; 38(1):12-6. PubMed ID: 26349120
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reporting of attributable and relative risks, 1966-97.
    Nakayama T; Zaman MM; Tanaka H
    Lancet; 1998 Apr; 351(9110):1179. PubMed ID: 9643696
    [No Abstract]   [Full Text] [Related]  

  • 46. Reading and interpreting research: focus on effect size.
    Holm K; Lanuza DM
    Prog Cardiovasc Nurs; 2008; 23(2):95-7. PubMed ID: 18843834
    [No Abstract]   [Full Text] [Related]  

  • 47. Interpreting measures of treatment effect in cancer clinical trials.
    Case LD; Kimmick G; Paskett ED; Lohman K; Tucker R
    Oncologist; 2002; 7(3):181-7. PubMed ID: 12065789
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The need for medicine-based evidence as well as evidence-based medicine.
    Tonkin AM
    Curr Atheroscler Rep; 2001 Mar; 3(2):97-8. PubMed ID: 11177652
    [No Abstract]   [Full Text] [Related]  

  • 49. [Risk, association, and impact measures in clinical research studies. How to interpret them for their application in medical care].
    Rendón-Macías ME; García H; Villasís-Keever MÁ
    Rev Alerg Mex; 2021; 68(1):65-75. PubMed ID: 34148329
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Foundational Statistical Principles in Medical Research: A Tutorial on Odds Ratios, Relative Risk, Absolute Risk, and Number Needed to Treat.
    Monaghan TF; Rahman SN; Agudelo CW; Wein AJ; Lazar JM; Everaert K; Dmochowski RR
    Int J Environ Res Public Health; 2021 May; 18(11):. PubMed ID: 34070675
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The number needed to treat: a clinically useful measure of treatment effect.
    Cook RJ; Sackett DL
    BMJ; 1995 Feb; 310(6977):452-4. PubMed ID: 7873954
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Number-needed-to-treat: translating benefits and risks of therapy from clinical trials to a clinical encounter.
    Ragan P; Quincy B
    J Physician Assist Educ; 2013; 24(1):45-9. PubMed ID: 23858826
    [No Abstract]   [Full Text] [Related]  

  • 53. Implementing GRADE: calculating the risk difference from the baseline risk and the relative risk.
    Newcombe RG; Bender R
    Evid Based Med; 2014 Feb; 19(1):6-8. PubMed ID: 23970740
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Measures of association: an overview with examples from Canadian emergency medicine research.
    Worster A; Rowe BH
    CJEM; 2001 Jul; 3(3):219-23. PubMed ID: 17610788
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Uses of error.
    Poynard T
    Lancet; 2002 Apr; 359(9316):1514. PubMed ID: 11988264
    [No Abstract]   [Full Text] [Related]  

  • 56. Common pitfalls in statistical analysis: Absolute risk reduction, relative risk reduction, and number needed to treat.
    Ranganathan P; Pramesh CS; Aggarwal R
    Perspect Clin Res; 2016; 7(1):51-3. PubMed ID: 26952180
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Interpreting the results of an article about therapy].
    Rivera S; Larrondo FJ; Ortega JP
    Rev Med Chil; 2005 May; 133(5):593-6. PubMed ID: 15970985
    [No Abstract]   [Full Text] [Related]  

  • 58. Estimating risk in clinical studies: odds ratio and risk ratio.
    Furcada JM; Patino CM; Ferreira JC
    J Bras Pneumol; 2020 Apr; 46(2):e20200137. PubMed ID: 32321148
    [No Abstract]   [Full Text] [Related]  

  • 59. Interpreting and applying absolute and relative risks from trials.
    Papageorgiou SN
    J Orthod; 2018 Jun; 45(2):135-137. PubMed ID: 29857793
    [No Abstract]   [Full Text] [Related]  

  • 60. Communicating study results to our patients: which way is best?
    Petrisor BA; Tornetta P
    Indian J Orthop; 2008 Apr; 42(2):140-3. PubMed ID: 19826518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.